Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis - Concepedia

Concepedia

Publication | Closed Access

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis

740

Citations

21

References

2000

Year

Timothy M. Cox, Robin Lachmann, C. E. Hollak, Johannes M. F. G. Aerts, Sonja van Weely, Martin Hřebı́ček, Frances M. Platt, Terry D. Butters, Raymond A. Dwek, Chris Moyses,

Ogt 918BiosynthesisMedicineSubstrate BiosynthesisMicrobiologyPharmacologyNovel Oral Treatment

References

	Year	Citations

Page 1